Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review

Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review

Objectives Assess values, preferences and burden of treatment that patients with type 2 diabetes consider when initiating glucagon-like peptide-1 receptor agonists (GLP-1 RA) or sodium-glucose cotransporter-2 inhibitors (SGLT-2i) compared with other glucose-lowering options.Methods Paired reviewers...

Full description

Bibliographic Details
Main Authors: Per Olav Vandvik, Qiukui Hao, Lyubov Lytvyn, Sheyu Li, Jose Gerardo González-González, Rene Rodriguez-Gutierrez, Suetonia C Palmer, Reem A Mustafa, Ricardo Cesar Solis, Alejandro Díaz González-Colmenero, Juan Manuel Millán-Alanís, Neri Alejandro Alvarez-Villalobos
Format: Article
Language:English
Published: BMJ Publishing Group 2021-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/7/e049130.full

Internet

https://bmjopen.bmj.com/content/11/7/e049130.full

Similar Items